<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30810666</article-id><article-id pub-id-type="pmc">6385838</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0358</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Surgical Treatment for Congenital Heart Defects in Down Syndrome
Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Fernando Cesar Gimenes Barbosa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1127-4782</contrib-id><name><surname>Croti</surname><given-names>Ulisses Alexandre</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Marchi</surname><given-names>Carlos Henrique De</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Murakami</surname><given-names>Alexandre Noboru</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, MSc</role></contrib><contrib contrib-type="author"><name><surname>Brachine</surname><given-names>Juliana Dane Pereira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PT</role></contrib><contrib contrib-type="author"><name><surname>Borim</surname><given-names>Bruna Cury</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>RN</role></contrib><contrib contrib-type="author"><name><surname>Finoti</surname><given-names>Renata Geron</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>de Godoy</surname><given-names>Moacir Fernandes</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Servi&#x000e7;o de Cardiologia e Cirurgia Cardiovascular
Pedi&#x000e1;trica de S&#x000e3;o Jos&#x000e9; do Rio Preto - Hospital da
Crian&#x000e7;a e Maternidade de S&#x000e3;o Jos&#x000e9; do Rio Preto (FUNFARME) -
Faculdade de Medicina de S&#x000e3;o Jos&#x000e9; do Rio Preto (FAMERP), S&#x000e3;o
Jos&#x000e9; do Rio Preto, SP, Brazil. </aff><aff id="aff2">
<label>2</label> Servi&#x000e7;o de Cirurgia Card&#x000ed;aca do Norte do
Paran&#x000e1;, Universidade Estadual de Londrina (UEL), Londrina, PR, Brazil. </aff><author-notes><corresp id="c1">Correspondence Address: <bold>Ulisses Alexandre Croti</bold>
https://orcid.org/0000-0002-1127-4782, Hospital da Crian&#x000e7;a e Maternidade
de S&#x000e3;o Jos&#x000e9; do Rio Preto (FUNFARME), Faculdade de Medicina de
S&#x000e3;o Jos&#x000e9; do Rio Preto (FAMERP), Av. Jamil Feres Kfouri, 60 -
S&#x000e3;o Jos&#x000e9; do Rio Preto, SP, Brazil, Zip Code: 15091-240. E-mail:
<email>ulissesacroti@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Feb</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2019</year></pub-date><volume>34</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><history><date date-type="received"><day>05</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To analyze data related to surgical treatment in patients with congenital
heart defects (CHD) and Down syndrome (DS) based on information from
International Quality Improvement Collaborative Database for Congenital
Heart Disease (IQIC).</p></sec><sec><title>Methods</title><p>Between July 1, 2010 and December 31, 2017, 139 patients with CHD and DS
underwent surgery at Hospital de Base and Hospital da Crian&#x000e7;a e
Maternidade de S&#x000e3;o Jos&#x000e9; do Rio Preto (FUNFARME)/Faculdade de
Medicina de S&#x000e3;o Jos&#x000e9; do Rio Preto - SP (FAMERP). A
quantitative, observational and cross-sectional study was performed in which
the pre, intra and postoperative data were analyzed in an IQIC database. The
data included gender, age, prematurity, weight, preoperative procedures,
diagnosis, associated cardiac and non-cardiac anomalies, Risk Adjustment for
Congenital Heart Surgery (RACHS-1), type of surgery, cardiopulmonary bypass
(CPB), perfusion time, aortic clamping time and CPB temperature, bacterial
sepsis, surgical site infection and other infections, length of stay in
intensive care unit (ICU), length of hospital stay and in-hospital
mortality.</p></sec><sec><title>Results</title><p>The most prevalent procedures were complete atrioventricular septal defect
repair (58 - 39.45%), followed by closure of ventricular septal defect (36 -
24.49%). The RACHS-1 categories 1, 2, 3 and 4 were distributed as 22 (15%);
49 (33.3%); 72 (49%) and 4 (2.7%), respectively. There were no procedures
classified as categories 5 or 6. Bacterial sepsis occurred in 10.2% of
cases, surgical site infection in 6.1%, other infections in 14.3%. The
median length of ICU stay was 5 days and the median length of hospital stay
was 11 days. In-hospital mortality was 6.8%.</p></sec><sec><title>Conclusion</title><p>Surgical treatment in patients with CHD and DS usually does not require
highly complex surgical procedures, but are affected by infectious
complications, resulting in a longer ICU and hospital length of stay with
considerable mortality.</p></sec></abstract><kwd-group><kwd>Down Syndrome</kwd><kwd>Heart Defects, Congenital</kwd><kwd>Database</kwd></kwd-group></article-meta></front><body><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AVSD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrioventricular septal
defect</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CHD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Congenital heart
defects</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Down syndrome</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ES</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Eisenmenger
syndrome</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IQIC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= International Quality
Improvement Collaborative</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Database for Congenital
Heart Disease</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PAH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pulmonary arterial
hypertension</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RACHS-1</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Risk Adjustment for
Congenital Heart Surgery</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Congenital heart defects (CHD) are present in patients with Down syndrome (DS) or
trisomy 21 in approximately 40-50% of cases<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.
Among the most common cardiac defects are atrioventricular septal defect (AVSD),
representing approximately 45% of cases, and ventricular septal defect (VSD),
representing 20-30%<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>The surgical treatment of CHD in these patients usually involves greater risk of
postoperative complications and mortality<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Adequate pre, intra and postoperative control can
be obtained with a reliable database. In our environment, data is stored in a
database entitled International Quality Improvement Collaborative for Congenital
Heart Disease (IQIC)<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>This international database, designed by Dr. Kathy J. Jenkins of Boston Children's
Hospital - Harvard Medical School, aims to reduce mortality and complications within
30 days of the procedure associated with pediatric cardiovascular surgery in
developing countries<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>Thus, we planned to analyze data related to surgical treatment in patients with CHD
and DS based on the information available in the IQIC database.</p></sec><sec sec-type="methods"><title>METHODS</title><p>From July 1 2010 to December 31 2017, 1,284 patients were operated at Hospital de
Base and at Hospital da Crian&#x000e7;a e Maternidade de S&#x000e3;o Jos&#x000e9; do
Rio Preto (FUNFARME)/Faculdade de Medicina de S&#x000e3;o Jos&#x000e9; do Rio Preto -
SP (FAMERP) and included into the IQIC database, of which 139 (10.83%) were patients
with CHD and DS.</p><p>A quantitative, observational and cross-sectional study was carried out in which pre,
intra and postoperative data of the 139 patients with CHD and DS included in the
IQIC database who underwent 147 surgical procedures were analyzed.</p><p>The information was collected through patients' electronic medical record and sent
via REDCap(r) platform to Boston Children's Hospital group at Harvard Medical
School, which periodically audits data through a face-to-face or Web-based visit to
identify possible failures. The data are analyzed and reported every six months to
the participating centers by the IQIC group, being compared with other participating
sites and within the center itself.</p><p>Preoperative data included gender, age at time of operation, history of prematurity,
weight, preoperative procedures, diagnosis, and presence of associated cardiac and
non-cardiac anomalies.</p><p>Intraoperative data included procedures Risk Adjustment for Congenital Heart Surgery
(RACHS-1), which ranks categories from 1 (lowest risk) to 6 (highest risk) and is a
useful tool for predicting the risk of mortality<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>Surgical descriptions of each patient were analyzed observing the type of surgery,
use of cardiopulmonary bypass (CPB), perfusion time, aortic clamping time and
temperature during CPB.</p><p>Post-operative data analysis included complications such as bacterial sepsis,
surgical site infection and other infections such as necrotizing enterocolitis,
tracheitis and pneumonia associated or not with mechanical ventilation, length of
hospital stay in intensive care unit (ICU), total length of hospital stay and
in-hospital mortality.</p><p>The number of patients was correlated to bacterial sepsis, surgical site infection
and other infections, as well as in-hospital mortality between 2010 and 2017.</p><p>Results were presented as an absolute number and a percentage for the qualitative
variables, as a mean &#x000b1; standard deviation or median and interquartile range
for the quantitative variables, in the most appropriate way.</p><p>The study was approved under the protocol number 2.963.344 for the FUNFARME / FAMERP
ethics committee (n&#x000ba; CAAE: 00177818.8.0000.5415). There was no need for a
free and informed consent term, since it involved only a collection of data from
patients' electronic records, not having direct contact with participants.</p></sec><sec sec-type="results"><title>RESULTS</title><p>The number of procedures per year was homogeneous (<xref ref-type="fig" rid="f1">Figure 1</xref>), with 2017 being the year with the highest number of
procedures (n=26) and 2010 with the lowest number of procedures (n=10), since there
were only 6 months in the database for the year 2010. There was a slight prevalence
of males over the females, 76 (51.7%) <italic>vs</italic>. 71 (48.3%). Three (2%)
patients were younger than 30 days old, 97 (66%) were between 30 days and younger
than 1 year old, and 47 (32%) were between 1 year and 17 years old, and 14 (9.5%)
with a history of prematurity. The median weight was 5.8 kg (IQR 4.6 - 8.3).</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Number of procedures in patients with Down syndrome (DS) between the
years 2010 to 2017.</p></caption><graphic xlink:href="rbccv-34-01-0001-g01"/></fig></p><p>For preoperative interventions, of 16 (10.9%) patients, 10 (6.8%) underwent
mechanical ventilation and 6 (4.1%) required inotropic drugs before surgery.</p><p>Data on main diagnosis of CHD are presented in <xref rid="t1" ref-type="table">Table
1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Main pre-operative congenital heart defects (CHD) diagnosis.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="70%" span="1"/><col width="30%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Diagnosis</th><th align="center" rowspan="1" colspan="1">N (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Complete atrioventricular septal defect</td><td align="center" rowspan="1" colspan="1">55 (39.57%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ventricular septal defect</td><td align="center" rowspan="1" colspan="1">35 (25.18%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tetralogy of Fallot</td><td align="center" rowspan="1" colspan="1">14 (10.07%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrial septal defect</td><td align="center" rowspan="1" colspan="1">13 (9.35%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Partial atrioventricular septal defect</td><td align="center" rowspan="1" colspan="1">8 (5.76%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Patent ductus arteriosus</td><td align="center" rowspan="1" colspan="1">7 (5.04%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Complete atrioventricular septal defect
(unbalanced)</td><td align="center" rowspan="1" colspan="1">3 (2.16%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Coarctation of the aorta</td><td align="center" rowspan="1" colspan="1">2 (1.44%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tricuspid atresia</td><td align="center" rowspan="1" colspan="1">1 (0.72%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulmonary stenosis (valvar and supravalvar)</td><td align="center" rowspan="1" colspan="1">1 (0.72%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">139 (100%)</td></tr></tbody></table></table-wrap><p>Evidence of pulmonary arterial hypertension (PAH) was reported in 15 (10.2%) of
cases. Eight (5.4%) patients had non-cardiac abnormalities associated, such as
Hirschsprung's syndrome, hypospadias, hypothyroidism and cleft palate.</p><p>The most prevalent procedures were complete AVSD repair with double patch technique
39 (26.53%), complete AVSD repair with "Australian technique" 13 (8.84%) and
complete AVSD repair with single patch technique 6 (4.08%), totalizing 58 (39.45%),
followed by VSD repair with bovine pericardial patch 29 (19.73%) and VSD repair with
bovine patch with tricuspid valve plasty 7 (4.76%), totalizing 36 (24.49%), as shown
in <xref rid="t2" ref-type="table">Table 2</xref>.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Main surgical procedures performed in patients with Down syndrome (DS).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="70%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Surgical procedures</th><th align="center" rowspan="1" colspan="1">Percentage (%)</th><th align="center" rowspan="1" colspan="1">RACHS-1 categories</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Complete AVSD repair with double patch technique</td><td align="center" rowspan="1" colspan="1">39 (26.53%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">VSD repair with bovine pericardial patch</td><td align="center" rowspan="1" colspan="1">29 (19.73%)</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Partial AVSD repair with left AV valve cleft repair +
ASD OP repair with bovine patch&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">11 (7.48%)</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">ASD repair with bovine patch&#x000a0;</td><td align="center" rowspan="1" colspan="1">13 (8.84%)</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Complete AVSD repair with "Australian technique"</td><td align="center" rowspan="1" colspan="1">7 (4.76%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">VSD repair with bovine patch + tricuspid valve
plasty</td><td align="center" rowspan="1" colspan="1">7 (4.76%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Double ligation of ductus arteriosus</td><td align="center" rowspan="1" colspan="1">7 (4.76%)</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Complete AVSD repair with single patch technique</td><td align="center" rowspan="1" colspan="1">6 (4.08%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Rastelli repair</td><td align="center" rowspan="1" colspan="1">5 (3.40%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Modified Blalock-Taussig shunt repair</td><td align="center" rowspan="1" colspan="1">4 (2.72%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Tetralogy of Fallot repair with transannular
patch&#x000a0;</td><td align="center" rowspan="1" colspan="1">4 (2.72%)</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Tetralogy of Fallot repair with pulmonary valve ring
preservation</td><td align="center" rowspan="1" colspan="1">3 (2.04%)</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulmonary artery banding</td><td align="center" rowspan="1" colspan="1">3 (2.04%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Glenn procedure + ASD enlargement</td><td align="center" rowspan="1" colspan="1">2 (1.36%)</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Aortic arch reconstruction</td><td align="center" rowspan="1" colspan="1">2 (1.36%)</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">ASD enlargement + pulmonary artery banding + plasty of
AV valves</td><td align="center" rowspan="1" colspan="1">1 (0.68%)</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">ASD enlargement + pulmonary artery banding + aortic
arch reconstruction</td><td align="center" rowspan="1" colspan="1">1 (0.68%)</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Tetralogy of Fallot repair + tricuspid valve
plasty</td><td align="center" rowspan="1" colspan="1">1 (0.68%)</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">ASD repair + pulmonar valve plasty</td><td align="center" rowspan="1" colspan="1">1 (0.68%)</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">VSD repair + Aortic arch reconstruction</td><td align="center" rowspan="1" colspan="1">1 (0.68%)</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">147 (100%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ASD=atrial septal defect; AV=atrioventricular; AVSD=atrioventricular
septal defect; OP=<italic>ostium primum</italic></p></fn></table-wrap-foot></table-wrap><p>CPB was performed in 129 (87.75%) surgical procedures, using a mean temperature of
28&#x000ba;C, mean perfusion time of 95 minutes and mean aortic clamping time of 64
minutes.</p><p>According to the RACHS-1 adjusted surgical risk category, 22 (15%) procedures were
placed into category 1, 49 (33.3%) in category 2, 72 (49%) in category 3 and 4
(2.7%) in category 4. There were no patients classified in risk categories 5 or 6 as
shown in <xref rid="t3" ref-type="table">Table 3</xref>.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Procedures according to RACHS-1 categories (Risk Adjustment for Congenital
Heart Surgery).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">RACHS-1 categories</th><th align="center" rowspan="1" colspan="1">Procedures (n)</th><th align="center" rowspan="1" colspan="1">Percentage (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">15%</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">33.3%</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">72</td><td align="center" rowspan="1" colspan="1">49%</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2.7%</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">100%</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>There were no procedures classified as categories 5 or 6. </p></fn></table-wrap-foot></table-wrap><p>Bacterial sepsis occurred in 10.2% of cases, surgical site infection in 6.1%, other
infections in 14.3% and in-hospital mortality in 6.8%, between the years 2010 to
2017, as shown in <xref rid="t4" ref-type="table">Table 4</xref> and <xref ref-type="fig" rid="f2">Figures 2</xref> and <xref ref-type="fig" rid="f3">3</xref>.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Postoperative complications related to the number of patients between 2010
and 2017.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Complications</th><th align="center" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1">Patients (n)</th><th align="center" rowspan="1" colspan="1">Results (n)</th><th align="center" rowspan="1" colspan="1">Percentage (%)</th></tr></thead><tbody><tr><td align="left" rowspan="9" colspan="1">Bacterial sepsis</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">40.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">21.4%</td></tr><tr><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">10.5%</td></tr><tr><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">13.6%</td></tr><tr><td align="center" rowspan="1" colspan="1">2015</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.8%</td></tr><tr><td align="center" rowspan="1" colspan="1">2016</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.2%</td></tr><tr><td align="center" rowspan="1" colspan="1">2017</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.2%</td></tr><tr><td align="center" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">10.2%</td></tr><tr><td align="left" rowspan="9" colspan="1">Surgical site infection</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">40.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5.3%</td></tr><tr><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2015</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.8%</td></tr><tr><td align="center" rowspan="1" colspan="1">2016</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">12.5%</td></tr><tr><td align="center" rowspan="1" colspan="1">2017</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">6.1%</td></tr><tr><td align="left" rowspan="9" colspan="1">Other infections</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">50.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">21.4%</td></tr><tr><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">15.8%</td></tr><tr><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">13.6%</td></tr><tr><td align="center" rowspan="1" colspan="1">2015</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">9.5%</td></tr><tr><td align="center" rowspan="1" colspan="1">2016</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">16.7%</td></tr><tr><td align="center" rowspan="1" colspan="1">2017</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.2%</td></tr><tr><td align="center" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">14.3%</td></tr><tr><td align="left" rowspan="9" colspan="1">In-hospital mortality</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">30.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">7.1%</td></tr><tr><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">15.4%</td></tr><tr><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2015</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.8%</td></tr><tr><td align="center" rowspan="1" colspan="1">2016</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">8.3%</td></tr><tr><td align="center" rowspan="1" colspan="1">2017</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.2%</td></tr><tr><td align="center" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">6.8%</td></tr></tbody></table></table-wrap><p><fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Comparison of postoperative results related to other infections between
the years 2010 to 2017.</p></caption><graphic xlink:href="rbccv-34-01-0001-g02"/></fig></p><p><fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Comparison of postoperative results related to in-hospital mortality
between the years 2010 to 2017.</p></caption><graphic xlink:href="rbccv-34-01-0001-g03"/></fig></p><p>There was also a significant reduction in all complications and in-hospital mortality
between the years, even with the increase in the number of patients operated,
decreasing from 50% to 6.1%.</p><p>Time of ICU hospitalization and total postoperative hospitalization time are
described in <xref rid="t5" ref-type="table">Table 5</xref>.</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Postoperative period intensive care unit and total length of stay.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Median</th><th align="center" rowspan="1" colspan="1">IQR (25% - 75%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ICU length of stay (days)</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">3 - 10</td></tr><tr><td align="left" rowspan="1" colspan="1">Total (days)</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">6 - 22</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>ICU=intensive care unit; IQR=interquartile range</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Since January 2002, 303 patients with CHD and DS were operated on. Understanding the
need to obtain highly reliable data, it was opted to analyze data exclusively
contained in the IQIC database which included 139 patients with CHD and DS after
July 1, 2010.</p><p>About 50% of individuals with DS are affected by CHD<sup>[<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>. The
increase in prevalence of DS leads to an increase in number of patients with cardiac
defects. A study published in the Annals of Thoracic Surgery in 2016 examined the
Society of Thoracic Surgeons (STS) database and revealed the prevalence of DS in
neonates undergoing cardiovascular surgery was 2.1%<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>Another meta-analysis published in 2017 on BMC Medical Genetics reported a higher
prevalence of female patients with CHD and DS<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. A different study published in 2016 in the
Scientific Journal of the Medical Association - Acta Medica Portuguesa showed that
64.7% of patients were female<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. A third study published in 2018 in the European Journal
of Pediatrics also showed a higher prevalence of females (52.7%)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. The present study,
however, revealed the opposite, with 51.7% of cases occurring in male patients.</p><p>More than half of procedures (68%) were performed in patients younger than one year
of age. This data is in agreement with another study previously published in the
Scientific Journal of the Medical Association - Acta Medica Portuguesa. This same
study showed a similar data regarding the weight at the time of the operation as the
median 6.4 kg (IQR 5.1 - 10.1), and in the present study the median was 5.8 kg (IQR
4.6 - 8.3)<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>The present study showed that the main CHD in DS patients was AVSD, in both complete
and partial forms, present in 63 (45.32%) of diagnosis, followed by VSD with 35
(25.18%) cases. A Swedish study published in 2016 reported similar prevalence, with
42% AVSD and 22% VSD<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. An Irish study published in 2018 also evidenced AVSD as
more frequent, present in 30% of cases<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. A third study in Germany evidenced the AVSD as
more frequent followed by VSD, 51.2% and 25.1% respectively<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>A study published in 2007 in the Annals of Thoracic Surgery that included 10,032
patients who underwent CHD correction categorized according to RACHS-1 showed
categories 2 and 3 as most common<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Data from the present study is in agreement, since
82.3% of the procedures also fit into categories 2 and 3. It is worth mentioning
that according to Cavalcante et al.<sup>[(13]</sup> although RACHS-1
has great ability to discriminate against mortality, this analysis, when performed
in developing countries, also needs to take into account the associated clinical
factors and structural and technological barriers.</p><p>Thus, it can be stated, according to the results of the present study and other
previous studies, that the majority of the procedures performed in patients with DS
are of RACHS-1 risk categories between 1 and 4, leaving the categories of high risk
(5 and 6) as a minority or absent in many centers.</p><p>Left-right shunt or increased pulmonary blood flow CHD will certainly evolve with
some degree of PAH<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. The unadjusted AVSD and VSD are the main
causes<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.
The present study demonstrated that 15 (10.20%) procedures were performed in
patients already with some evidence of PAH, according to observations collected from
surgical descriptions. When untreated, these patients can progress to Eisenmenger
syndrome (ES), the final stage of PAH, when the right-left shunt is reversed, with
high morbidity and mortality. In order to avoid this evolution, it has been
recommended to operate these patients before 6 months of age, or even between 3 and
4 months in some centers<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p><p>The presence of non-cardiac anomalies is six times higher in patients with DS
compared to those without chromosomal anomalies, with gastrointestinal tract
malformations being the most common. However, a Norwegian study published in 2018 in
the Act Paediatrics revealed that in patients with DS and CHD, the association with
extracardiac malformations was not as frequent<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>Even so, all cases of esophageal atresia and 10 of the 11 cases of Hirschsprung's
disease reported occurred in patients with CHD. In the present study, no association
was observed with esophageal atresia; however, one patient presented Hirschsprung's
disease and another patient had already undergone correction of ileus atresia.</p><p>Infection is one of the complications most feared by surgeons and team in the
postoperative period of cardiovascular surgery. This is due to the intimate
relationship between presence of infection and increased mortality and length of
hospital stay.</p><p>Sepsis is a much-feared postoperative complication due to the related mortality rate.
Ma et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>
published in 2007 that sepsis accounted for 11% of deaths in the postoperative
period of congenital heart surgery. Barker et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> showed a sepsis rate of 2.6% in series
with 30,078 cases. Our study evidenced that 15 (10.2%) procedures evolved with
sepsis, however, the relation of these sepsis cases with in-hospital mortality was
not performed. It is important to mention that the infection rate decreased from 40%
in 2010 to 4.2% in 2017, as observed in <xref rid="t4" ref-type="table">Table
4</xref>.</p><p>Regarding surgical site infection (SSI), a study conducted at Boston Children's
Hospital and published in the Annals of Thoracic Surgery in 2010 concluded that age
younger than 1 year and CPB time greater than 105 minutes are independent risk
factors for any type of SSI, as well as aortic clamping time greater than 85 minutes
and at least 3 postoperative red blood cell transfusions as risk factors for the
development of mediastinitis<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. The Boston study's SSI rate was 2.16% (73 cases in
3367 procedures), lower than the total rate of the present study of 6.12% (9 cases
out of 147 procedures), but no SSI was diagnosed in the year of 2017.</p><p>Barker et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>
analyzed the STS database and found an infection rate of 2.8% (857 infections in
30,078 cases). They also reported a mortality rate of 22.2% in cases with infection
against 3% in those without infection, and a longer hospitalization time of 21 days
in 69.9% of the cases associated with the infection compared to 10.7% in cases
without infection.</p><p>Patients with DS are more susceptible both to viral and bacterial infections and to
the development of leukemia, and this has been attributed to the disordered immune
system, which is one of the pathological features of the syndrome<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Non-immunological factors
such as airway and ear abnormalities and also gastroesophageal reflux are also
related to this susceptibility<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>.</p><p>Major immunological changes in this group of patients include reduction in T and B
lymphocyte counts, absence of normal lymphocyte expansion in childhood, reduced size
of the thymus, suboptimal response to immunizations, total and specific reduction of
immunoglobulin A in saliva and neutrophils with decreased
chemotaxis<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>.</p><p>This explains why this group of patients, even when submitted to procedures with
lower levels of complexity, is affected with more infections than the general
population.</p><p>The present study showed ICU hospitalization in the postoperative period with a
median time of 5 days (IQR: 3-10), probably due to the reduced availability of ward
beds. As a result of this problem, several patients who receive treatment in this
center and are apt for discharge to the ward are sometimes discharged directly from
the ICU to home.</p><p>The median time of total postoperative hospitalization observed in the present study
was 11 days (IQR: 6 - 22) and this can be related to the infection rate in the
postoperative period, which, as is scientifically proven, significantly increases
postoperative in-hospital length of stay, even though the study did not correlate
infection cases with increased length of hospitalization specifically.</p><p>Regarding mortality of DS patients submitted to CHD repair, Dias et
al.<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>
reported a rate of 2.9% (3/102 cases) in 30 days. The mortality rate of the STS
database for pediatric patients undergoing cardiovascular surgery was 4%, not
specifying patients with and without DS. In the present study, there were 10 (6.8%)
intra-hospital deaths among the procedures analyzed, being 4.2% in 2017, but still
higher than those reported in previous studies<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><sec><title>Limitation</title><p>The limitations of the study are related to single center data analysis and
non-correlation of infection cases that resulted in increased hospitalization
and in-hospital mortality.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Surgical treatment in patients with CHD and DS usually does not require highly
complex surgical procedures, but are affected by infectious complications, resulting
in a longer ICU and hospital length of stay with considerable mortality.</p><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" valign="top" rowspan="1">Authors' roles &#x00026;
responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">FCGBS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to conception or
design of the work; or the acquisition, analysis, or interpretation
of data for the work; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UAC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to conception or
design of the work; or the acquisition, analysis, or interpretation
of data for the work; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CHM</td><td align="left" valign="top" rowspan="1" colspan="1">Final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ANM</td><td align="left" valign="top" rowspan="1" colspan="1">Final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JDPB</td><td align="left" valign="top" rowspan="1" colspan="1">Final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BCB</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting of the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RGF</td><td align="left" valign="top" rowspan="1" colspan="1">Final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MFG</td><td align="left" valign="top" rowspan="1" colspan="1"> Drafting of the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Servi&#x000e7;o de Cardiologia e Cirurgia
Cardiovascular Pedi&#x000e1;trica de S&#x000e3;o Jos&#x000e9; do Rio Preto do
Hospital da Crian&#x000e7;a e Maternidade de S&#x000e3;o Jos&#x000e9; do Rio Preto
(FUNFARME) da Faculdade de Medicina de S&#x000e3;o Jos&#x000e9; do Rio Preto
(FAMERP), SP, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaiasu</surname><given-names>V</given-names></name></person-group><article-title>Down syndrome: genetics and cardiogenetics</article-title><source>Maedica (Buchar)</source><year>2017</year><volume>12</volume><issue>3</issue><fpage>208</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">29218069</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lal</surname><given-names>PS</given-names></name><name><surname>Chavan</surname><given-names>B</given-names></name><name><surname>Devendran</surname><given-names>VR</given-names></name><name><surname>Varghese</surname><given-names>R</given-names></name><name><surname>Murmu</surname><given-names>UC</given-names></name><name><surname>Kumar</surname><given-names>RS</given-names></name></person-group><article-title>Surgical outcome of congenital heart disease in Down's
syndrome</article-title><source>Asian Cardiovasc Thorac Ann</source><year>2013</year><volume>21</volume><issue>2</issue><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">24532614</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x000f6;m</surname><given-names>S</given-names></name><name><surname>Carr</surname><given-names>H</given-names></name><name><surname>Petersson</surname><given-names>G</given-names></name><name><surname>Stephansson</surname><given-names>O</given-names></name><name><surname>Bonamy</surname><given-names>AK</given-names></name><name><surname>Dahlstr&#x000f6;m</surname><given-names>A</given-names></name><etal/></person-group><article-title>Trends in congenital heart defects in infants with Down
syndrome</article-title><source>Pediatrics</source><year>2016</year><volume>138</volume><issue>1</issue><!--<pub-id pub-id-type="pii">e20160123</pub-id>--></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croti</surname><given-names>UA</given-names></name><name><surname>Braile</surname><given-names>DM</given-names></name></person-group><article-title>Thoughts regarding the situation of the pediatric cardiovascular
surgery in Brazil</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>3</issue><fpage>3</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">27737413</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>KJ</given-names></name><name><surname>Casta&#x000f1;eda</surname><given-names>AR</given-names></name><name><surname>Cherian</surname><given-names>KM</given-names></name><name><surname>Couser</surname><given-names>CA</given-names></name><name><surname>Dale</surname><given-names>EK</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><etal/></person-group><article-title>Reducing mortality and infections after congenital heart surgery
in the developing world</article-title><source>Pediatrics</source><year>2014</year><volume>134</volume><issue>5</issue><fpage>e1422</fpage><lpage>e1430</lpage><pub-id pub-id-type="pmid">25311607</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>KJ</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Spray</surname><given-names>TL</given-names></name><name><surname>Moller</surname><given-names>JH</given-names></name><name><surname>Iezzoni</surname><given-names>LI</given-names></name></person-group><article-title>Consensus-based method for risk adjustment for surgery for
congenital heart disease</article-title><source>J Thorac Cardiovasc Surg</source><year>2002</year><volume>123</volume><issue>1</issue><fpage>110</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">11782764</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>FM</given-names></name><name><surname>Cordeiro</surname><given-names>S</given-names></name><name><surname>Menezes</surname><given-names>I</given-names></name><name><surname>Nogueira</surname><given-names>G</given-names></name><name><surname>Teixeira</surname><given-names>A</given-names></name><name><surname>Marques</surname><given-names>M</given-names></name><etal/></person-group><article-title>Congenital heart disease in children with Down syndrome: what has
changed in the last three decades?</article-title><source>Acta Med Port</source><year>2016</year><volume>29</volume><issue>10</issue><fpage>613</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">28103457</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Costello</surname><given-names>JM</given-names></name><name><surname>Backer</surname><given-names>CL</given-names></name><name><surname>Pasquali</surname><given-names>SK</given-names></name><name><surname>Hill</surname><given-names>KD</given-names></name><name><surname>Wallace</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Prevalence of noncardiac and genetic abnormalities in neonates
undergoing cardiac operations: analysis of The Society of Thoracic Surgeons
Congenital Heart Surgery Database</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>102</volume><issue>5</issue><fpage>1607</fpage><lpage>1614</lpage><pub-id pub-id-type="pmid">27319986</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diogenes</surname><given-names>TCP</given-names></name><name><surname>Mourato</surname><given-names>FA</given-names></name><name><surname>Lima Filho</surname><given-names>JL</given-names></name><name><surname>Mattos</surname><given-names>SDS</given-names></name></person-group><article-title>Gender differences in the prevalence of congenital heart disease
in Down's syndrome: a brief meta-analysis</article-title><source>BMC Med Genet</source><year>2017</year><volume>18</volume><issue>1</issue><fpage>111</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">28985718</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Breatnach</surname><given-names>CR</given-names></name><name><surname>Kent</surname><given-names>E</given-names></name><name><surname>Shanahan</surname><given-names>I</given-names></name><name><surname>Boyle</surname><given-names>M</given-names></name><etal/></person-group><article-title>Infants born with Down syndrome: burden of disease in the early
neonatal period</article-title><source>J Pediatr</source><year>2018</year><volume>193</volume><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">29174996</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfitzer</surname><given-names>C</given-names></name><name><surname>Helm</surname><given-names>PC</given-names></name><name><surname>Rosenthal</surname><given-names>LM</given-names></name><name><surname>Berger</surname><given-names>F</given-names></name><name><surname>Bauer</surname><given-names>UMM</given-names></name><name><surname>Schmitt</surname><given-names>KR</given-names></name></person-group><article-title>Dynamics in prevalence of Down syndrome in children with
congenital heart disease</article-title><source>Eur J Pediatr</source><year>2018</year><volume>177</volume><issue>1</issue><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">29127498</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benavidez</surname><given-names>OJ</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><name><surname>Del Nido</surname><given-names>P</given-names></name><name><surname>Bacha</surname><given-names>E</given-names></name><name><surname>Jenkins</surname><given-names>KJ</given-names></name></person-group><article-title>Complications and risk factors for mortality during congenital
heart surgery admissions</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>84</volume><issue>1</issue><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">17588402</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalcante</surname><given-names>CT</given-names></name><name><surname>Souza</surname><given-names>NMG</given-names></name><name><surname>Pinto J&#x000fa;nior</surname><given-names>VC</given-names></name><name><surname>Branco</surname><given-names>KM</given-names></name><name><surname>Pompeu</surname><given-names>RG</given-names></name><name><surname>Teles</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Analysis of surgical mortality for congenital heart defects using
RACHS-1 Risk Score in a Brazilian single center</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>3</issue><fpage>219</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">27737404</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimopoulos</surname><given-names>K</given-names></name><name><surname>Kempny</surname><given-names>A</given-names></name></person-group><article-title>Patients with Down syndrome and congenital heart disease:
survival is improving, but challenges remain</article-title><source>Heart</source><year>2016</year><volume>102</volume><issue>19</issue><fpage>1515</fpage><lpage>1517</lpage><pub-id pub-id-type="pmid">27354276</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nir</surname><given-names>A</given-names></name><name><surname>Berkman</surname><given-names>N</given-names></name></person-group><article-title>Clinical and parental status of patients with congenital heart
disease associated pulmonary arterial hypertension</article-title><source>Isr Med Assoc J</source><year>2017</year><volume>19</volume><issue>8</issue><fpage>489</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">28825767</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodwall</surname><given-names>K</given-names></name><name><surname>Greve</surname><given-names>G</given-names></name><name><surname>Leirgul</surname><given-names>E</given-names></name><name><surname>Klungs&#x000f8;yr</surname><given-names>K</given-names></name><name><surname>Holmstr&#x000f8;m</surname><given-names>H</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name><etal/></person-group><article-title>The five-year survival of children with Down syndrome in Norway
1994-2009 differed by associated congenital heart defects and extracardiac
malformations</article-title><source>Acta Paediatr</source><year>2018</year><volume>107</volume><issue>5</issue><fpage>845</fpage><lpage>853</lpage><pub-id pub-id-type="pmid">29341296</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><name><surname>Allan</surname><given-names>CK</given-names></name><name><surname>Mayer Jr</surname><given-names>JE</given-names></name><name><surname>Jenkins</surname><given-names>KJ</given-names></name></person-group><article-title>Causes of death after congenital heart surgery</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>83</volume><issue>4</issue><fpage>1438</fpage><lpage>1445</lpage><pub-id pub-id-type="pmid">17383354</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>GM</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Welke</surname><given-names>KF</given-names></name><name><surname>Jacobs</surname><given-names>ML</given-names></name><name><surname>Jacobs</surname><given-names>JP</given-names></name><name><surname>Benjamin Jr</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Major infection after pediatric cardiac surgery: a risk
estimation model</article-title><source>Ann Thorac Surg</source><year>2010</year><volume>89</volume><issue>3</issue><fpage>843</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">20172141</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costello</surname><given-names>JM</given-names></name><name><surname>Graham</surname><given-names>DA</given-names></name><name><surname>Morrow</surname><given-names>DF</given-names></name><name><surname>Morrow</surname><given-names>J</given-names></name><name><surname>Potter-Bynoe</surname><given-names>G</given-names></name><name><surname>Sandora</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Risk factors for surgical site infection after cardiac surgery in
children</article-title><source>Ann Thorac Surg</source><year>2010</year><volume>89</volume><issue>6</issue><fpage>1833</fpage><lpage>1842</lpage><pub-id pub-id-type="pmid">20494036</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>FP</given-names></name><name><surname>Marinoni</surname><given-names>M</given-names></name><name><surname>Frangione</surname><given-names>V</given-names></name><name><surname>Tedeschi</surname><given-names>A</given-names></name><name><surname>Gandini</surname><given-names>V</given-names></name><name><surname>Ciglia</surname><given-names>F</given-names></name><etal/></person-group><article-title>Down syndrome, autoimmunity and T regulatory
cells</article-title><source>Clin Exp Immunol</source><year>2012</year><volume>169</volume><issue>3</issue><fpage>238</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">22861363</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram</surname><given-names>G</given-names></name><name><surname>Chinen</surname><given-names>J</given-names></name></person-group><article-title>Infections and immunodeficiency in Down syndrome</article-title><source>Clin Exp Immunol</source><year>2011</year><volume>164</volume><issue>1</issue><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">21352207</pub-id></element-citation></ref></ref-list></back></article>